Palbokaas 125mg Capsule is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as cyclin-dependent kinase inhibitors. It is used in treating hormone receptor-positive, human epidermal growth factor 2–negative advanced or metastatic breast cancer, and this aligns with Palbokaas 125mg Capsule uses in clinical practice. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. This medicine is given in combination with certain other anticancer medications.

The common Palbokaas 125mg side effects include nausea, vomiting, diarrhea, tiredness, hair loss, dry skin, rash, infections, nosebleeds, decreased appetite, low blood cell counts, swelling of the lips and mouth, taste changes, dry eyes, blurred vision, and increased tearing. Inform your doctor if any of these side effects disturb or persist. Inform your healthcare provider if you are allergic to Palbokaas 125mg Capsule or any of its ingredients. Before taking this medicine, it is vital to inform your doctor if you have any signs of infection (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to certain sugars.

Consult your physician immediately if you experience symptoms such as dry cough, chest pain, or difficulty breathing, as these could indicate lung inflammation. Make sure you inform your physician of all the medicines, including supplements and herbal products, you are taking before starting this medication. Use effective birth control during the treatment and for at least three weeks after the last dose. This medicine is not recommended for adolescents and children under 18 years of age. If required, your doctor may consider a suitable Palbokaas 125mg substitute based on your medical condition and treatment tolerance.